These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 30275409)
21. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
22. The impact of peer management on test-ordering behavior. Neilson EG; Johnson KB; Rosenbloom ST; Dupont WD; Talbert D; Giuse DA; Kaiser A; Miller RA; Ann Intern Med; 2004 Aug; 141(3):196-204. PubMed ID: 15289216 [TBL] [Abstract][Full Text] [Related]
23. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567 [TBL] [Abstract][Full Text] [Related]
24. Regulatory approval for new pharmacogenomic tests: a comparative overview. Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844 [TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory. Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700 [TBL] [Abstract][Full Text] [Related]
27. Top ten challenges when interfacing a laboratory information system to an electronic health record: Experience at a large academic medical center. Petrides AK; Tanasijevic MJ; Goonan EM; Landman AB; Kantartjis M; Bates DW; Melanson SEF Int J Med Inform; 2017 Oct; 106():9-16. PubMed ID: 28870384 [TBL] [Abstract][Full Text] [Related]
28. Insurance coverage for pharmacogenomic testing in the USA. Williams MS Per Med; 2007 Nov; 4(4):479-487. PubMed ID: 29793275 [TBL] [Abstract][Full Text] [Related]
30. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287 [TBL] [Abstract][Full Text] [Related]
31. Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services. Hicks JK; Stowe D; Willner MA; Wai M; Daly T; Gordon SM; Lashner BA; Parikh S; White R; Teng K; Moss T; Erwin A; Chalmers J; Eng C; Knoer S Pharmacotherapy; 2016 Aug; 36(8):940-8. PubMed ID: 27312955 [TBL] [Abstract][Full Text] [Related]
32. Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing. Cuffe S; Hon H; Qiu X; Tobros K; Wong CK; De Souza B; McFarlane G; Masroor S; Azad AK; Hasani E; Rozanec N; Leighl N; Alibhai S; Xu W; Issa AM; Liu G Pharmacogenet Genomics; 2014 Jul; 24(7):348-55. PubMed ID: 24911662 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics and Psychiatric Nursing. White MM; Walker DK; Howington LL; Cheek DJ Issues Ment Health Nurs; 2019 Feb; 40(2):194-198. PubMed ID: 30451558 [TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas. Dorfman EH; Brown Trinidad S; Morales CT; Howlett K; Burke W; Woodahl EL Pharmacogenomics; 2015; 16(3):227-37. PubMed ID: 25712186 [TBL] [Abstract][Full Text] [Related]
35. Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. Gammal RS; Mayes J; Caudle KE J Am Pharm Assoc (2003); 2019; 59(5):646-650. PubMed ID: 31327749 [TBL] [Abstract][Full Text] [Related]
36. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria. Natsuhara KH; Losk K; King TA; Lin NU; Camuso K; Golshan M; Pochebit S; Brock JE; Bunnell CA; Freedman RA Oncologist; 2019 May; 24(5):595-602. PubMed ID: 30076279 [TBL] [Abstract][Full Text] [Related]
40. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]